These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1976875)

  • 21. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction.
    Jacobsson F; Swahn E; Wallentin L; Ellborg M
    Clin Ther; 2002 May; 24(5):752-65. PubMed ID: 12075943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.
    Lewis HD; Davis JW; Archibald DG; Steinke WE; Smitherman TC; Doherty JE; Schnaper HW; LeWinter MM; Linares E; Pouget JM; Sabharwal SC; Chesler E; DeMots H
    N Engl J Med; 1983 Aug; 309(7):396-403. PubMed ID: 6135989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of unstable angina after the discontinuation of heparin.
    Théroux P; Waters D; Lam J; Juneau M; McCans J
    N Engl J Med; 1992 Jul; 327(3):141-5. PubMed ID: 1608405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.
    Théroux P; Waters D; Qiu S; McCans J; de Guise P; Juneau M
    Circulation; 1993 Nov; 88(5 Pt 1):2045-8. PubMed ID: 8222097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
    Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
    Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unstable angina: status of aspirin and other forms of therapy.
    Lewis HD
    Circulation; 1985 Dec; 72(6 Pt 2):V155-60. PubMed ID: 3905054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
    Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contemporary opinions on the use of aspirin, heparin and thrombolytic therapy in unstable angina pectoris--pathogenetic findings versus results of many clinical tests].
    Popiel M; Grajek S; Cieśliński A
    Przegl Lek; 1996; 53(1):33-40. PubMed ID: 8711174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
    Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence on platelet function by heparin in men with unstable coronary artery disease.
    Berglund U; Wallentin L
    Thromb Haemost; 1991 Dec; 66(6):648-51. PubMed ID: 1796408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction?
    Larsson H; Areskog M; Areskog NH; Nylander E; Nyman I; Swahn E; Wallentin L
    Int J Card Imaging; 1991; 7(1):7-14. PubMed ID: 1753161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
    Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin, heparin, or both to treat unstable angina.
    N Engl J Med; 1989 Apr; 320(15):1014-5. PubMed ID: 2633752
    [No Abstract]   [Full Text] [Related]  

  • 38. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.
    Juul-Möller S; Edvardsson N; Jahnmatz B; Rosén A; Sørensen S; Omblus R
    Lancet; 1992 Dec; 340(8833):1421-5. PubMed ID: 1360557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.
    Lancet; 1999 Aug; 354(9180):701-7. PubMed ID: 10475180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.